Get the Stockscreener App
0.3326
3.59%
-0.0124
Pre-market:
.32
-0.0126
-3.79%
Catheter Precision Inc. stock is traded at $0.3326, with a volume of 3.21M.
It is down -3.59% in the last 24 hours and up +14.65% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$0.345
Open:
$0.3443
24h Volume:
3.21M
Relative Volume:
0.27
Market Cap:
$2.85M
Revenue:
$24,000
Net Income/Loss:
$-78.06M
P/E Ratio:
-0.0115
EPS:
-28.9956
Net Cash Flow:
$-21.81M
1W Performance:
+46.91%
1M Performance:
+14.65%
6M Performance:
-2.49%
1Y Performance:
-93.60%
1-Day Range:
$0.2801
$0.3802
1-Week Range:
$0.2491
$0.8253
52-Week Range:
$0.1648
$8.40
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.3326 | 2.85M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
Catheter Precision Inc (VTAK) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Catheter Precision (STU:4RM0) Momentum Rank : 9 (As of Jun. 15, 2025) - GuruFocus
Catheter Precision, Inc. Comments on Recent Market Activity | VT - GuruFocus
Catheter Precision, Inc. Comments on Recent Market Activity - The Manila Times
Catheter Precision, Inc. Addresses Increased Trading Activity in Common Stock - Nasdaq
Catheter Precision, Inc. Comments On Recent Market Activity - Barchart.com
Catheter Precision Issues Urgent Statement on Unexplained Stock Movement, Reveals Strategic Plans - Stock Titan
Catheter Precision (VTAK) Sees Record High Sales for LockeT in Q - GuruFocus
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product | VTAK Stock News - GuruFocus
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product - The Manila Times
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Catheter Precision Inc (VTAK) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
catheter precision issues stock warrant to ladenburg thalmann By Investing.com - Investing.com Canada
catheter precision issues stock warrant to ladenburg thalmann - Investing.com Australia
Catheter Precision (VTAK) Receives First Order for VIVO from Swe - GuruFocus
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgr - GuruFocus
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital - The Manila Times
Largest Swedish Hospital Chooses Catheter Precision VIVO: Major Win in Scandinavian Cardiac Market - Stock Titan
Catheter Precision Approves Warrant Issuance to Ladenburg - TipRanks
catheter precision announces executive change By Investing.com - Investing.com South Africa
Catheter Precision Announces CCO Departure and Leadership Change - TipRanks
catheter precision announces executive change - Investing.com
Catheter Precision, Inc. Receives Ce Mark for LockeT - marketscreener.com
Catheter Precision (VTAK) Achieves CE Mark Approval for LockeT D - GuruFocus
Catheter Precision Receives CE Mark Approval for LockeT Vascular Closure Device - marketscreener.com
Catheter Precision, Inc. Receives CE Mark for LockeT | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives CE Mark Approval for LockeT, Expanding Market Opportunities in Europe - Nasdaq
Catheter Precision, Inc. Receives CE Mark for LockeT - The Manila Times
Catheter Precision Unlocks $4.3B European Market with CE Mark: First Orders Already Flowing - Stock Titan
Catheter Precision, Inc. Receives CE Mark for LockeT | VTAK Stoc - GuruFocus
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Catheter Precision Inc Files For Resale Of Up To 12.9 Million Shares Of Common Stock By The Selling StockholdersSEC Filing - marketscreener.com
Catheter Precision Enters Market Offering Agreement - MSN
Catheter Precision Enters At Market Offering Agreement With Ladenburg Thalmann & Co. IncSEC Filing - marketscreener.com
QHSLab Signals Debt Restructuring - citybiz
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth - TradingView
Breakthrough Patent: How Autonomix Medical's New Nerve-Mapping Tech Could Transform Pain Treatment - Stock Titan
Catheter Precision revenue increases 74% to USD 143K in Q1 2025 - Medical Buyer
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results - The Manila Times
Catheter Precision Q1 Revenue Surges 74% as Clinical Studies Show 94% Accuracy in Heart Procedures - Stock Titan
Catheter Precision Enters Securities Purchase Agreement - TipRanks
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Cap:
|
Volume (24h):